Saying bye slowly makes parting easier
Last days of my INVEST fellowship
Visiting research scholars make new friends quickly and parting is not always easy for them. I said bye in Portland (OR) five times:
First, I said bye to my writing group. This was my second group in the last 15 weeks. The first, 10-week course of prompt-based writing was a birthday gift from my wife. I enjoyed the first course so much that I decided to go for a second round. The new beginnings were difficult, because we had a new group and group dynamics; dynamics matters most in writing groups. By the 3rd-4thmeeting, the group juice started to flow and we shared more and more feedback on our writings. Parting with the second group wasn’t easy, but much smoother thanks to my experience with the first group; I felt I belong there.
My point here – that saying bye slowly makes parting easier – should interest most visiting research scholars. Beyond this limited audience, however, my point should speak to anyone who faces parting with many good friends.
Pedicabs, Cochrane & Drugs Conference in San Diego
I was in San Diego (CA) 9 years ago. We went there with my wife, then a girlfriend, on a J1 Student work & travel programme. We worked as pedicab drivers – did not make much money but got the best tan (and time) in our lives. This year, we returned to Sand Diego for my presentation at the conference of the College on Problems of Drugs Dependence.
The drugs conference
This was probably the biggest conference I’ve ever attended. I underestimated the power that such enormous scientific stimulation can have on my thinking and experiencing of the world of addictions. My notebook is again full of ideas for research and life. To share just one of them, Wyoming is the only state in which has free access to Cochrane reviews in US. Cochrane collaboration is committed to produce high quality reviews of scientific evidence which aim to change the clinical practice and policy. USA produces the biggest number of studies that get included in Cochrane reviews. Are they not interested in reading what Cochrane reviews make of their clinical trials?
As I was coming back from the conference hotel to my hostel in the down town, I passed by an older man in red jacket entering the historical Simmons hotel with a bag of groceries. ‘I used to live here, 9 months ago’ said I when I saw him. ‘Nine years ago, I used to be a general manager of this hotel’ was his response. Back then, it was very difficult to convince this stern man that we would be able to pay our rent from our pedicab money. His face glowed when he finished our small talk ‘It’s a nice place to live’.
The pedicabs
To my big surprise, we haven’t seen many pedicabs on the streets of San Diego. But it didn’t discourage us from taking a memorial ride from the US Midway to down town. We stopped a driver from Canada wearing a US flag as his head band. He explained what has caused the decline of pedicabs in SD:
- no J1 student drivers allowed (since 2009)
- the upper limit of new licenses – drop from 600 to 200
- Californian driving license required (since 2011)
- insurance for all
… we still didn’t manage to get on the Midway, maybe next time.
My new friend Portland, John Fitzgerald, PhD, wrote about this conference too, in his June blog.
My itinerary for the Conference – College on Problems of Drug Dependence, San Diego, June 15-20
INVEST-ing: Jan Klimas teams up with US university

Jan Klimas, PhD, joins the Western States Node on March 1, 2013, as a NIDA CTN INVEST Fellow. NIDA is the National Institute on Drug Abuse, and INVEST is International Visiting Scientists & Technical Exchange Program for drug abuse research. Oregon Health & Sciences University hosts Dr. Klimas’ six months fellowship during which he will assess the use of Screening and Brief Intervention (SBIRT) for alcohol use disorders among patients receiving agonist medication for opioid use disorders.
Professor Dennis McCarty, Co-PI for the Western States Node, will supervise Dr. Klimas during his fellowship. The research examines addiction treatment in primary and specialty care settings with respect to implementation of screening and treatment for unhealthy alcohol use among opioid-dependent patients in methadone or buprenorphine agonist treatment in Ireland and Oregon. Dr. Klimas’ prior work in Ireland informs the U.S. investigation… Read more in the NIDA CTN bulletin, issue November 15th, 2012: (http://ctndisseminationlibrary.org/bulletin/20121115.pdf)